Health
EMA expects Johnson & Johnson to file for vaccine approval within days – The Irish Times
New BioNTech production site will have capacity to produce 750m doses annually
The European Medicines Agency (EMA) expects Johnson & Johnson to file for approval of its Covid-19vaccine in the EU within the next few days. Approval of this inoculation is viewed by many as pivotal in speeding up the overall rollout of vaccines, in part because it may only require one dose.
The news came as existing Covid-19 vaccine developer BioNTech begun production at a second plant in Germany, significantly boosting its output for world markets.
BioNTechs new plant in Marburg, an hour north…
-
Business20 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Noosa News17 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business16 hours agoDicker Data rides the AI trend to double digit growth
-
Business19 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy